Evidence map›Paper›PMID 34917730›Full record

ArticleGynecologic oncology reports2022

Breast cancer risk in

Andrea Nañez, Douglas A Stram, C Bethan Powell, Christine Garcia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Counselling Framework for GermlineCurrent oncology (Toronto, Ont.) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrea NañezDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
Douglas A StramDivision of Research, Kaiser Permanente Northern California, Oakland, CA, United States.
C Bethan PowellDivision of Gynecologic Oncology, Kaiser Permanente Northern California Hereditary Cancer Program, San Francisco, CA, United States.
Christine GarciaDivision of Gynecologic Oncology, Kaiser Permanente Northern California Hereditary Cancer Program, San Francisco, CA, United States.
Kaiser Permanente · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEvaluate the incidence and characteristics of breast cancers (BC) diagnosed following an epithelial ovarian cancer (EOC) diagnosis in women with pathogenic

methodsRetrospective cohort study of all women in an integrated healthcare system with

resultsThere were 284 women with

conclusionsMost BC following

Indexed as

BRCABreast cancerGenetic testingOvarian cancerScreening

Identifiers

PMID34917730
PMCPMC8666339
OpenAlexW4200275480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.